ID Source | ID |
---|---|
PubMed CID | 197063 |
CHEMBL ID | 122577 |
CHEBI ID | 187906 |
SCHEMBL ID | 26114 |
MeSH ID | M0146428 |
Synonym |
---|
brn 2345158 |
phosphonothioic acid, methyl- |
methylphosphonothioic acid |
methylphosphonothiolate |
bdbm50131869 |
CHEMBL122577 , |
methyl-phosphonothioic acid |
dihydroxy-methyl-sulanylidene-lambda5-phosphane |
CHEBI:187906 |
5994-73-0 |
methanephosphonothioic acid |
AKOS006277926 |
SCHEMBL26114 |
DTXSID70208652 |
dihydroxy-methyl-sulfanylidene-lambda5-phosphane |
Class | Description |
---|---|
organothiophosphorus compound | An organothiophosphorus compound is an organophosphorus compound which contains a phosphorus-sulfur bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
dephosphorylation | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
defense response | Protein tyrosine phosphatase receptor type C-associated protein | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
alkaline phosphatase activity | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
metal ion binding | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
protein binding | Protein tyrosine phosphatase receptor type C-associated protein | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
extracellular region | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
plasma membrane | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
side of membrane | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
plasma membrane | Alkaline phosphatase, germ cell type | Homo sapiens (human) |
plasma membrane | Protein tyrosine phosphatase receptor type C-associated protein | Homo sapiens (human) |
plasma membrane | Protein tyrosine phosphatase receptor type C-associated protein | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID164683 | Inhibitory activity against Serine/Threonine Protein phosphatase 2C (PP2C) | 2003 | Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17 | A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors. |
AID213547 | Inhibitory activity against Tyrosine phosphatase from Yersinia (Yop protein) | 2003 | Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17 | A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors. |
AID32833 | Inhibitory activity against Escherichia coli Alkaline Phosphatase; no inhibition | 2003 | Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17 | A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors. |
AID159822 | Inhibition of Human Placental alkaline Phosphatase (PLAP) | 2003 | Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17 | A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors. |
AID99563 | Inhibitory activity against Serine/Threonine Protein Phosphatase (Lambda protein phosphatase) | 2003 | Journal of medicinal chemistry, Aug-14, Volume: 46, Issue:17 | A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.76) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |